Federal mandate to cover 'reversal' care for gender-affirming procedures sparks insurance, medical c

What it does

This bill requires health insurance plans and issuers that cover gender-affirming medical procedures to also cover medical treatment for complications and harms from those procedures—including surgical revision, hormone management, mental health care, and fertility restoration—with the same cost-sharing and coverage limits as other medical benefits. The bill defines 'sex-rejecting procedures' broadly to include puberty blockers, cross-sex hormones, and surgeries, and mandates coverage of 'restorative care' to address physical, psychological, and reproductive harms, effective January 1, 2027.

Why we flagged it

The bill's operative mechanism is a straightforward insurance coverage mandate—plans covering gender-affirming procedures must also cover treatment for complications. However, the bill's language, definitions, and framing (e.g., 'sex-rejecting,' 'restore healthy human form') embed a particular ideological stance on gender-affirming medicine rather than neutral medical language, making this both a coverage mandate and a statement of contested medical philosophy.

What the text implies

• The bill's definition of 'restorative care' is extremely broad and includes psychiatric/psychological treatment for 'identity distress' and 'regret'—potentially mandating coverage of conversion therapy-adjacent mental health interventions, depending on state law and plan interpretation.
• The mandate applies retroactively to individuals who received procedures before the bill's effective date ('at any point during the individual's lifetime'), creating open-ended liability for insurers for past procedures and potentially triggering coverage disputes over causation.
• The bill's exclusion for 'disorders of sex development' (DSD) is narrow and clinically specific, but the definition of 'sex' as 'genetically determined at fertilization' may conflict with medical standards for DSD diagnosis and treatment, creating litigation risk.
• By mandating coverage of 'fertility services' that 'restore healthy physiology' without 'circumventing natural human functions,' the bill may exclude or restrict coverage of assisted reproductive technologies (IVF, egg/embryo handling) for individuals who have undergone gender-affirming care, even when medically necessary.
• The bill's application to both group and individual health insurance markets, combined with the broad definition of covered harms, may incentivize insurers to exclude or limit coverage of gender-affirming procedures themselves to avoid triggering the mandate—creating a de facto coverage restriction.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates a new insurance mandate requiring coverage of medical treatment for complications from gender-affirming care, which may benefit individuals experiencing adverse effects and ensures equal cost-sharing. However, the bill's framing and expansive definition of 'harms' and 'sex-rejecting procedures'—including routine cosmetic surgeries and fertility services—reflects a contested policy position on gender-affirming medicine itself, and the mandate may increase insurance costs or reduc

Who stands to gain

• surgical and medical device manufacturers (revision surgeries, prosthetics, implants)
• mental health and rehabilitation service providers
• pharmaceutical companies (hormone management, complication treatment)
• fertility clinics and reproductive medicine specialists

Named in the bill

Health insurance issuers, Group health plans, ERISA, Public Health Service Act, Internal Revenue Code, Johnson & Johnson (JNJ), Bristol Myers Squibb (BMY), AIG, Facebook (FBK), Prudential (PRU)

Where it stands

14 cosponsors: 14 Republicans.

• Jul 16, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jul 16, 2026 — Referred to House Committee on Ways and Means and House Committee on Education and Workforce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.